Other Information
+Added: As previously reported in our Current Report on Form 8-K filed with the SEC on May 27, 2022, in a non-binding advisory vote held at the 2022 Annual Meeting of Stockholders on the frequency of future say-on-pay votes regarding the compensation of our named executive officers, our stockholders expressed their preference for a say-on-pay vote to be conducted every one year.
+Added: After taking into consideration the voting results and the prior recommendation of our board of directors in favor of an annual stockholder advisory vote on the compensation of our named executive officers, our board of directors intends to hold future advisory votes on the compensation of our named executive officers every year.
+Added: Our board of directors will re-evaluate this determination after the next stockholder advisory vote on the frequency of say-on-pay votes (which will be at the 2028 Annual Meeting of Stockholders, unless presented earlier).
Fourth Amended and Restated Certificate of Incorporation of Relay Therapeutics, Inc.
1 unchanged sentence
001-39385) filed on July 21, 2020).
+Added: Certificate of Amendment of Fourth Amended and Restated Certificate of Incorporation of Relay Therapeutics, Inc.
+Added: (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K (File No.
+Added: 001-39385) filed on May 27, 2022).
Amended and Restated Bylaws of Relay Therapeutics, Inc.
1 unchanged sentence
001-39385) filed on July 21, 2020).
−Removed: Amendment No.
−Removed: AR3 to Amended and Restated Collaboration and License Agreement, by and between the Registrant and D.E.
−Removed: Shaw Research, LLC, dated January 27, 2022.
−Removed: First Amendment to Collaboration and License Agreement, by and between the Registrant and Genentech, Inc.
−Removed: Hoffmann-La Roche Ltd, dated February 2, 2022.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
14 unchanged sentences
Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.
−Removed: Portions of this exhibit (indicated by asterisks) have been omitted pursuant to Item 601(b)(10) of Regulation S-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
RELAY THERAPEUTICS, INC.
+Added: August 4, 2022
/S/ SANJIV K.
1 unchanged sentence
(Principal Executive Officer)
+Added: August 4, 2022
/S/ THOMAS CATINAZZO
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.